HER2 CISH Gene Amplification Test Now Available CARLSBAD, Calif.–Invitrogen Corporation, (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, has signed an exclusive U.S. distribution agreement with Biocare Medical LLC, a leading provider of immunohistochemistry reagents, multiplex stains, and automated platforms for the anatomic pathology market, for the new SPOT-Light® HER2 […]
bioMerieux, a world leader in the field of in vitro diagnostics has acquired the privately held AviaraDx, Inc., a molecular in vitro diagnostics company, based in San Diego, California (USA). AviaraDx’s diagnostic tests, based on their proprietary technologies, are used in the molecular classification of cancers and to assist oncologists in making critical therapeutic decisions. […]
MUNICH, Germany–The Advalytix product team of Olympus is initiating a collaborative study with The University of Texas M. D. Anderson Cancer Center to characterize circulating tumor cells in breast cancer patients. The study combines Advalytix’s sensitive AmpliGrid molecular analysis platform, multiplex primer design, and integrated workflow to analyze expression of multiple target genes in single […]
The CDC to Develop MSI’s Back-Scattering Interferometry Technologyas a Diagnostic Platform for the Detection of Infectious Disease and Typing of Causative Agents Montara, California, September 9th, 2008- Today, Molecular Sensing, Inc. (MSI), an early stage biotechnology company, announces the signing of a Cooperative Research and Development Agreement (CRADA) with the Centers for Disease Control’s, National […]
AUSTIN, Texas & CYPRESS, Calif.–Asuragen, Inc., announces that it has granted Focus Diagnostics, Inc., the infectious disease diagnostics company of Quest Diagnostics, non-exclusive worldwide rights to incorporate Armored RNA® technology into its in vitro molecular diagnostics products. Under the terms of the Agreement, Asuragen will develop and supply reagents for Focus Diagnostics in Asuragen’s QSR-compliant […]
NEW YORK, Sept. 5 — eGenomics, Inc., a leader in the development of state of the art genomic and informational systems for infectious disease control, announced today that the United States Patent and Trademark Office (USPTO) recently issued U.S. Patent no. 7,449,808, for key elements of its proprietary warning system for hospital infection control. The […]
Sample Processing for aCGH-Based Genetic Tests September 03, 2008, SciGene (Sunnyvale, CA) and ARUP Laboratories (Salt Lake City, UT) announced today they have entered into an agreement under which they will develop an automated platform for processing DNA samples used in microarray-based tests used for detecting genetic defects. Under the agreement, SciGene will provide the […]
Over 70 CytoVision(R) workstations to provide an automated solution for Scotland’s entire network of cytogenetic laboratories NEW MILTON, UK–Genetix Group plc (AIM: GTX), the cancer diagnostic and biopharmaceutical technologies group, today announces that it has been awarded a contract to develop and implement a nationwide network of Automated Cytogenetic Analysis Systems by NHS National Services […]
Eine deutsche Version finden Sie weiter unten QIAGEN Unveils Diagnostic Assay in the EU to Detect Genetic Variation Causing Adverse Reactions in AIDS Patients HLA-B*5701 biomarker indicates risk for severe adverse reactions to Abacavir / Experts expect more tests for similar markers in the future Venlo, The Netherlands – August 19, 2008 – QIAGEN (Nasdaq: […]
WINNIPEG, MANITOBA Miraculins Inc. (TSX VENTURE: MOM), a medical diagnostic company focused on developing and commercializing diagnostic tests for unmet clinical needs, is pleased to announce that the Company has completed development of a prototype assay for PSP94 (Prostate Secretory Protein) on the Luminex Bio-Plex 200 Protein Array System and plans to manufacture and begin […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
